Picture of Solvonis Therapeutics logo

SVNS Solvonis Therapeutics News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Solvonis Therapeutics Says NIDA To Fund Early Preclinical Evaluation Of Svn-015

Dec 3 (Reuters) - Solvonis Therapeutics PLC SVNS.L:

NIDA TO FUND EARLY PRECLINICAL EVALUATION OF SVN-015

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Solvonis Therapeutics

See all news